Infectious Diseases News and Research

RSS

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the side effects of antibiotics and the occurrence of severe Clostridium difficile infections.

13 May 2014

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex Corporation today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™.

From Luminex 12 May 2014

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Pfizer Inc. announced today the results from two Phase 2 studies of bivalent rLP2086, Pfizer's recombinant vaccine candidate, currently under development for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25 year olds.

12 May 2014

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.

12 May 2014

Researcher receives $3.3 million grant from NIH to find way for curing HIV

A George Mason University researcher has won a $3.3 million grant from the National Institutes of Health (NIH) that may lead to a way for curing HIV in the next five years.

12 May 2014

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild.

8 May 2014

Study encourages schools to be more aware of hand-washing

Dr. Michael Gabriel of GPM Pediatrics, a New York based Pediatric Center, comments on an article that says children are more likely to wash their hands when someone is around or watching. This new study could prove to be useful in reducing the amount of infectious diseases contracted by children.

8 May 2014

Scientists find 2 key proteins that regulate growth of mammary stem cells and contribute to breast cancer

By carefully controlling the levels of two proteins, researchers at the Salk Institute have discovered how to keep mammary stem cells-those that can form breast tissue-alive and functioning in the lab. The new ability to propagate mammary stem cells is allowing them to study both breast development and the formation of breast cancers.

8 May 2014

Researchers create universal flu vaccine

Researchers at the University of Texas Medical Branch are working to create a universal flu vaccine - one that could eliminate the need for an annual flu shot.

8 May 2014

FDA-cleared BD MAX Enteric Bacterial Panel now available to detect bacterial pathogens

BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the FDA-cleared BD MAX Enteric Bacterial Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 7 May 2014

TGen/George Mason create strategic research alliance to benefit patients with cancer, life-threatening illnesses

The Translational Genomics Research Institute (TGen) and George Mason University today announced the creation of a strategic research alliance to benefit patients with cancer and other life-threatening illnesses.

7 May 2014

Surgical site infection guidelines provide real-world strategies to reduce number of infections

Surgical site infections (SSIs) are the most common and costly healthcare-associated infection (HAI) in the United States.

7 May 2014

New expert guidance encourages healthcare institutions to implement prevention efforts infectious diarrhea

With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.

7 May 2014

Johns Hopkins researchers awarded NIH contract to launch new center to track influenza viruses

The National Institutes of Health has awarded a contract to researchers at The Johns Hopkins University to launch a new center devoted to developing innovative ways to identify and track influenza viruses worldwide.

6 May 2014

Virtual patient, medical record and questions appear effective in recognizing suicide risk

A virtual patient, the electronic medical record, and questions about how well patients sleep appear effective new tools in recognizing suicide risk, researchers say.

6 May 2014

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

Consumption of alcohol has long been associated with an increased risk of advanced liver fibrosis, but a new study published online in Clinical Infectious Diseases from researchers at Penn Medicine and other institutions shows that association is drastically heightened in people co-infected with both HIV and chronic hepatitis C virus (HCV) infection.

5 May 2014

Trends, opportunities and threats in the life science industry: an interview with Bob Coughlin, CEO, MassBio

We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.

5 May 2014

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.

1 May 2014

Decker Foundation gift helps Binghamton University to establish lab for improving health outcomes

A gift from the Dr. G. Clifford & Florence B. Decker Foundation will enable Binghamton University biologists and their colleagues to conduct tests and research that will improve health outcomes for patients in Southern Tier hospitals with conditions ranging from ear infections to cancer.

30 Apr 2014

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

30 Apr 2014

Infectious Diseases News and Research

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Researcher receives $3.3 million grant from NIH to find way for curing HIV

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

Study encourages schools to be more aware of hand-washing

Scientists find 2 key proteins that regulate growth of mammary stem cells and contribute to breast cancer

Researchers create universal flu vaccine

FDA-cleared BD MAX Enteric Bacterial Panel now available to detect bacterial pathogens

TGen/George Mason create strategic research alliance to benefit patients with cancer, life-threatening illnesses

Surgical site infection guidelines provide real-world strategies to reduce number of infections

New expert guidance encourages healthcare institutions to implement prevention efforts infectious diarrhea

Johns Hopkins researchers awarded NIH contract to launch new center to track influenza viruses

Virtual patient, medical record and questions appear effective in recognizing suicide risk

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

Trends, opportunities and threats in the life science industry: an interview with Bob Coughlin, CEO, MassBio

Biotech to the rescue

Decker Foundation gift helps Binghamton University to establish lab for improving health outcomes

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News